These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. Luo X; Stock C; Burwinkel B; Brenner H PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963 [TBL] [Abstract][Full Text] [Related]
3. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia. Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573 [TBL] [Abstract][Full Text] [Related]
4. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer. Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555 [TBL] [Abstract][Full Text] [Related]
5. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774 [TBL] [Abstract][Full Text] [Related]
7. Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer. Faltejskova P; Bocanek O; Sachlova M; Svoboda M; Kiss I; Vyzula R; Slaby O Cancer Biomark; 2012; 12(4):199-204. PubMed ID: 23568010 [TBL] [Abstract][Full Text] [Related]
8. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer. Luo X; Wu Y; Ji M; Zhang S Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212 [TBL] [Abstract][Full Text] [Related]
10. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Wang LG; Gu J Cancer Epidemiol; 2012 Feb; 36(1):e61-7. PubMed ID: 22018950 [TBL] [Abstract][Full Text] [Related]
11. microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma. Yau TO; Wu CW; Dong Y; Tang CM; Ng SS; Chan FK; Sung JJ; Yu J Br J Cancer; 2014 Oct; 111(9):1765-71. PubMed ID: 25233396 [TBL] [Abstract][Full Text] [Related]
12. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602 [TBL] [Abstract][Full Text] [Related]
13. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
14. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer. Xu L; Li M; Wang M; Yan D; Feng G; An G BMC Cancer; 2014 Sep; 14():714. PubMed ID: 25255814 [TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702 [TBL] [Abstract][Full Text] [Related]
16. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer. Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793 [TBL] [Abstract][Full Text] [Related]
17. Examining plasma microRNA markers for colorectal cancer at different stages. Sun Y; Liu Y; Cogdell D; Calin GA; Sun B; Kopetz S; Hamilton SR; Zhang W Oncotarget; 2016 Mar; 7(10):11434-49. PubMed ID: 26863633 [TBL] [Abstract][Full Text] [Related]
18. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649 [TBL] [Abstract][Full Text] [Related]
19. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer. Nonaka R; Miyake Y; Hata T; Kagawa Y; Kato T; Osawa H; Nishimura J; Ikenaga M; Murata K; Uemura M; Okuzaki D; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M Int J Oncol; 2015 Sep; 47(3):1097-102. PubMed ID: 26134152 [TBL] [Abstract][Full Text] [Related]
20. A panel of microRNA signature in serum for colorectal cancer diagnosis. Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]